Get started
Author

Lama Sharara

Observed name: L. Sharara
Institution: Fondation ARCAD
Observed institution: Fondation ARCAD
OpenAlex ID: A5089169302
Pancreatic Cancer From the Patient Perspective: The Time to Act is Now
2022 · Marianna Vitaloni, Patrick Michl, et al. · Journal of Patient Experience · 5
PDF
Bevacizumab in first-line therapy in lung metastases of colorectal cancer: An ARCAD pooled analysis.
2023 · Einat S Shmueli, Morteza Raeisi, et al. · Journal of Clinical Oncology
Using T stage to predict outcomes of adjuvant oxaliplatin (OX)-based chemotherapy (CT) in stage III colon cancer (CC): An ACCENT pooled analysis.
2022 · Romain Cohen, Morteza Raeisi, et al. · Journal of Clinical Oncology
SO-22 Clinical classification-based evaluation of adjuvant therapy with oxaliplatin in stage II colon cancer
2022 · B. Chibaudel, M. Raeisi, et al. · Annals of Oncology
First-line (L1) therapy targeting EGFR in lung metastases (mets) of colorectal cancer (mCRC): An ARCAD pooled analysis.
2022 · Einat Shacham Shmueli, Morteza Raeisi, et al. · Journal of Clinical Oncology
Works count: 5
Citation count: 5
H-index: 1
I10-index:
Year
Topic
Type